Intervention

positron emission tomography

ClinicalTrials.gov intervention label

Clinical trials31
Recruiting0
Common conditions25
Lead sponsors shown15

Clinical trials

31 shown
Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's DiseaseNCT06224920 · 2017-01-01
COMPLETED
Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate CancerNCT02169063 · 2015-12-01
WITHDRAWN
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerNCT02293954 · 2015-11-11
ACTIVE_NOT_RECRUITING
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast CancerNCT02226276 · 2015-01-07
ACTIVE_NOT_RECRUITING
Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CTNCT02119065 · 2014-01-30
ACTIVE_NOT_RECRUITING
Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate CancerNCT01967862 · 2013-12-01
COMPLETED
Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate CancerNCT01812668 · 2013-03-01
COMPLETED
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone TherapyNCT01720602 · 2012-11-01
COMPLETED
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast CancerNCT01931709 · 2011-11-01
TERMINATED
Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung CancerNCT01789892 · 2011-06-01
WITHDRAWN
Positron Emission Tomography in Women With Advanced HER2-Positive Breast CancerNCT01093612 · 2011-03-16
ACTIVE_NOT_RECRUITING
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor TherapyNCT01153672 · 2010-11-01
COMPLETED
Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate CancerNCT00956163 · 2010-03-01
COMPLETED
Relationship Between Thoracic Aortic Structure Assessed B PET/CT Scan and Arterial Stiffness in Elderly PatientsNCT01963221 · 2010-01-01
COMPLETED
F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast CancerNCT00602043 · 2008-09-01
COMPLETED
FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung CancerNCT00564733 · 2007-10-01
COMPLETED
Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast CancerNCT00755313 · 2007-05-01
COMPLETED
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerNCT00471835 · 2007-01-01
WITHDRAWN
PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast CancerNCT00362973 · 2006-05-01
COMPLETED
Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung CancerNCT00310219 · 2006-02-01
COMPLETED
Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By SurgeryNCT00303901 · 2005-11-01
COMPLETED
PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung MetastasesNCT00382252 · 2005-05-02
COMPLETED
Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung CancerNCT00083083 · 2005-03-01
UNKNOWN
11C Topotecan PET ImagingNCT00253461 · 2004-12-01
TERMINATED
Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and ChemotherapyNCT00450567 · 2004-12-01
COMPLETED
Clinical, Molecular and Metabolic Characteristics of Parkinson's Disease (PD) Patients With Parkin MutationNCT00169364 · 2002-05-01
UNKNOWN
Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast CancerNCT00039286 · 2001-10-01
COMPLETED
Positron Emission Tomography for Detecting Non-small Cell Lung CancerNCT00004138 · 1999-09-01
COMPLETED
PET Scans in Patients With Locally Advanced Breast CancerNCT00109785 · 1997-03-01
COMPLETED
PET Scan in Treating Patients With Metastatic Prostate CancerNCT00002981 · 1997-01-01
COMPLETED
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by SurgeryNCT00002930 · 1996-12-01
COMPLETED

Common conditions

Lung Cancer10Breast Cancer6Stage IV Breast Cancer5Metastatic Cancer4Recurrent Breast Cancer4Recurrent Prostate Cancer4Male Breast Cancer3Stage IV Prostate Cancer3Unspecified Adult Solid Tumor, Protocol Specific3Bone Metastases2Hormone-resistant Prostate Cancer2Liver Metastases2Adenocarcinoma of the Prostate1Advanced Adult Primary Liver Cancer1Aging1Alzheimer Disease1Chemotherapeutic Agent Toxicity1Cognitive/Functional Effects1Colon Cancer1Corticobasal Syndrome1Esophageal Cancer1Estrogen Receptor-positive Breast Cancer1Extrahepatic Bile Duct Cancer1Fatigue1Gallbladder Cancer1

Leading sponsors

University of Washington6City of Hope Medical Center4Memorial Sloan Kettering Cancer Center4Barbara Ann Karmanos Cancer Institute2National Cancer Institute (NCI)2Alliance for Clinical Trials in Oncology1American College of Radiology Imaging Network1Case Comprehensive Cancer Center1Central Hospital, Nancy, France1Groupe Hospitalier Pitie-Salpetriere1Institut Bergonié1Jonsson Comprehensive Cancer Center1Ludwig-Maximilians - University of Munich1Ohio State University Comprehensive Cancer Center1Radiation Therapy Oncology Group1

Trial status mix

COMPLETED20
ACTIVE_NOT_RECRUITING4
WITHDRAWN3
TERMINATED2
UNKNOWN2

Phase mix

NA17
PHASE25
PHASE13
EARLY_PHASE12
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.